Home|
Costly Cancer Drug Offers Hope, but Also a Dilemma Avastin, which can cost as much as $100,000 a year, has become one of the most popular cancer drugs, but studies show it prolongs life by only a few months. Home > Rss Directory > General > NY Time |
|
Costly Cancer Drug Offers Hope, but Also a Dilemma Avastin, which can cost as much as $100,000 a year, has become one of the most popular cancer drugs, but studies show it prolongs life by only a few months. Home > Rss Directory > Business > NY Time |
|
The Evidence Gap: Costly Cancer Drug Offers Hope, but Also a Dilemma Avastin, which can cost as much as $100,000 a year, has become one of the most popular cancer drugs, but studies show it prolongs life by only a few months. Home > Rss Directory > General > NY Time |
|
The Evidence Gap: Costly Cancer Drug Offers Hope, but Also a Dilemma Avastin, which can cost as much as $100,000 a year, has become one of the most popular cancer drugs, but studies show it prolongs life by only a few months. Home > Rss Directory > Business > NY Time |
|
Gallery: A Little Hope for Cancer Treatment : Photo: Dave Bullock/Wired.comLOS ANGELES -- UCLA scientists have developed a process for targeting cancer cells that could eliminate some of the worst side effects of chemotherapy. The new technique deploys nanoscale, light-activated containers filled with cancer-fighting drugs throughout the b Home > Rss Directory > General > Wired News |
|
Gallery: A Little Hope for Cancer Treatment : Photo: Dave Bullock/Wired.comLOS ANGELES -- UCLA scientists have developed a process for targeting cancer cells that could eliminate some of the worst side effects of chemotherapy. The new technique deploys nanoscale, light-activated containers filled with cancer-fighting drugs throughout the b Home > Rss Directory > Technology > Wired News |
|
Bone Drug Offers Hope on Breast Cancer Study: Zometa might be alternative to chemo for early-stage breast cancer. Home > Rss Directory > General > ABC News |
|
Drug Companies Get Healthy, but at Whose Expense? News from Portfolio.com Also on Portfolio Esquire, E-Ink: Future of Print? Hollywood's Sudden Cash Crunch Even Conservatives Hate Michael Savage Subscribe to Portfolio magazine Trevor Foltz was six months old last fall, Home > Rss Directory > General > Wired News |
|
Drug Companies Get Healthy, but at Whose Expense? News from Portfolio.com Also on Portfolio Esquire, E-Ink: Future of Print? Hollywood's Sudden Cash Crunch Even Conservatives Hate Michael Savage Subscribe to Portfolio magazine Trevor Foltz was six months old last fall, Home > Rss Directory > Technology > Wired News |
|
Study: Bone Loss Drug Fights Spread of Breast Cancer Doctors make an exciting discovery that a drug used to prevent bone loss during breast cancer treatment also substantially cuts the risk that the cancer will return. Home > Rss Directory > General > Wired News |
|
Study: Bone Loss Drug Fights Spread of Breast Cancer Doctors make an exciting discovery that a drug used to prevent bone loss during breast cancer treatment also substantially cuts the risk that the cancer will return. Home > Rss Directory > Technology > Wired News |
|
Breast Cancer Drug Approved - Washington Post dBTechnoBreast Cancer Drug ApprovedWashington Post - Feb 23, 2008A drug to treat breast cancer received approval yesterday from the Food and Drug Administration, which went against the recommendation of its advisory panel.Genentech's Avastin wins OK to treat breast Home > Rss Directory > General > Google News |
|
UPDATE 1-Drug prevents bone loss in prostate cancer - Amgen - Reuters Ontario NowUPDATE 1-Drug prevents bone loss in prostate cancer - AmgenReuters - 3 hours agoBy Deena Beasley LOS ANGELES, July 14 (Reuters) - In a study, Amgen Inc's (AMGN.O: Quote, Profile, Research) experimental drug denosumab reduced the risk of osteoporosis and fract Home > Rss Directory > General > Google News |
|
Cheap drug hope for breast cancer A combination of two inexpensive existing drugs may offer a new way to treat breast cancer, a study suggests. Home > Rss Directory > General > BBC |
|
Narcolepsy drug helps cancer-related fatigue: study - Reuters Canada.comNarcolepsy drug helps cancer-related fatigue: studyReuters - 1 hour agoCHICAGO (Reuters) - The narcolepsy drug Provigil can alleviate severe cancer-related fatigue, according to new research presented on Saturday at a meeting of the American Society for Clinic Home > Rss Directory > General > Google News |
|
MacroGenics Buys Drug Developer to Bolster Cancer Work The orphaned Raven has found a parent. MacroGenics, a Rockville biotech, announced yesterday that it bought cancer drug developer Raven Biotechnologies of South San Francisco, Calif. Until last March, it looked like another biotech firm would be adopting Raven. VaxGen, also of South San Francisco... Home > Rss Directory > Technology > WashingtonPost |
|
Genetic test in three years to detect prostate cancer - Guardian Unlimited Dog Flu Diet and DiseasesGenetic test in three years to detect prostate cancerGuardian Unlimited - 3 hours agoA genetic test that identifies men most at risk of prostate cancer could be available within three years, scientists said yesterday.Prostate cancer screeni Home > Rss Directory > General > Google News |
|
FDA Investigates Possible Vytorin-Cancer Link - U.S. News & World Report dBTechnoFDA Investigates Possible Vytorin-Cancer LinkU.S. News & World Report - Aug 22, 2008By Ed Edelson THURSDAY, Aug. 21 (HealthDay News) -- US drug regulators said Thursday that they were investigating whether the cholesterol-lowering drug Vytorin might be linked to Home > Rss Directory > General > Google News |
|
FDA Breast Cancer Drug Approval Prompts Mixed Reaction In a surprise decision that could represent a shift in standards for assessing the effectiveness of cancer medicines, the FDA clears Avastin for use in treating breast cancer. The federal agency is judging the drug's effectiveness based on measurements of tumor growth, not patient survival. Home > Rss Directory > General > Wired News |
|
FDA Breast Cancer Drug Approval Prompts Mixed Reaction In a surprise decision that could represent a shift in standards for assessing the effectiveness of cancer medicines, the FDA clears Avastin for use in treating breast cancer. The federal agency is judging the drug's effectiveness based on measurements of tumor growth, not patient survival. Home > Rss Directory > Technology > Wired News |